Winona Skin Balance Gel vs. French ACM Gel: Which Is Better for Skin Repair?

When selecting a topical agent for managing mild-to-moderate acne or post-inflammatory skin sensitivity, clinicians and patients often compare products with similar indications but differing formulations. Two frequently discussed options are Winona’s Jingheng Gel (marketed in China) and the French ACM Acne Control Gel. While both target sebum regulation and epidermal barrier support, they differ significantly in composition, mechanism of action, and clinical evidence base.

Winona Jingheng Gel is a Chinese dermatological formulation containing centella asiatica extract, niacinamide, and panthenol—ingredients selected for their anti-inflammatory, antioxidant, and barrier-repair properties. Clinical studies conducted in Chinese populations report improvements in erythema, transepidermal water loss (TEWL), and subjective stinging after four weeks of twice-daily use in individuals with sensitive, acne-prone skin. However, peer-reviewed publications on this product remain limited outside regional journals, and robust randomized controlled trials comparing it head-to-head with established international standards are lacking.

In contrast, ACM Acne Control Gel is a CE-marked medical device developed in France, formulated with 5% micronized sulfur and 2% salicylic acid. Its mechanism centers on keratolytic action, follicular declogging, and antimicrobial modulation—notably against Cutibacterium acnes. Published data—including a 12-week multicenter trial in the European Journal of Dermatology—demonstrated statistically significant reductions in inflammatory lesion count and improved skin tolerance compared to vehicle control, with minimal irritation even in patients with reactive skin.

Regarding barrier repair efficacy, Jingheng Gel shows measurable short-term improvement in hydration and redness reduction, consistent with its soothing ingredient profile. Yet it does not possess direct comedolytic or antibacterial activity. ACM Gel, while primarily designed for lesion control, also supports barrier integrity indirectly through reduced inflammation and microbial load—though its higher concentration of active exfoliants may require gradual introduction in highly sensitive individuals.

Clinically, choice between these agents should be individualized: Jingheng Gel may suit patients prioritizing gentle calming during recovery from irritation or retinoid-induced sensitivity; ACM Gel is better indicated when primary concerns include active comedones, papules, or pustules requiring targeted antimicrobial and keratolytic intervention. Neither replaces first-line prescription therapies for moderate-to-severe acne, and both should be integrated into a comprehensive regimen that includes sun protection and non-comedogenic moisturization.